Errors During Delivery Rarely Cause Newborn Brain Damage

This article originally appeared here.
Share this content:
Errors During Delivery Rarely Cause Newborn Brain Damage
Errors During Delivery Rarely Cause Newborn Brain Damage

MONDAY, Feb. 1, 2016 (HealthDay News) -- Few cases of severe brain damage in newborns are due to errors made during delivery, according to a new, small study published online Jan. 21 in the Journal of Perinatology.

Jonathan Muraskas, M.D., co-medical director of the neonatal intensive care unit at Loyola University Medical Center in Chicago and professor in the department of pediatrics of Loyola University Chicago Stritch School of Medicine, and colleagues analyzed the medical records of 32 full-term infants with cerebral palsy and mental retardation.

The cases examined included 18 newborns with chorioamnionitis, and 14 newborns with severe anemia. The researchers found that early-onset seizures, multiorgan failure, and a partial prolonged injury to the cortex and subcortical white matter were associated with profound depression with low 10-min Apgars (88, 94, and 94 percent, respectively). In 68 percent of newborns, a cord arterial pH >7.00 was noted; in just 19 percent of the newborns, deep gray matter injury involving the basal ganglia and thalamus occurred.

"The cord arterial pH and partial pressure of carbon dioxide values, early-onset seizures, and paucity of isolated deep gray matter injury support that significant injury occurred postnatally despite appropriate resuscitation," the authors write. "This unique pattern may refute allegations of obstetrical mismanagement in the intrapartum period."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »